Factors such as age, breast surgery type, concurrent DCIS, TNM stage, tumor grade, LVI, NI, HR status, and ERBB2 status were found to be associated with survival in patients with different histopathological types. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.